Logo

AVNT

Avient Corporation

AVNT

Avient Corporation NYSE
$30.59 0.72% (+0.22)

Market Cap $2.80 B
52w High $51.73
52w Low $27.48
Dividend Yield 1.08%
P/E 24.87
Volume 193.72K
Outstanding Shares 91.56M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $806.5M $172.3M $32.6M 4.042% $0.36 $123M
Q2-2025 $866.5M $181.8M $52.6M 6.07% $0.57 $142.2M
Q1-2025 $826.6M $262.5M $-20.2M -2.444% $-0.22 $45.6M
Q4-2024 $746.5M $173.9M $48.3M 6.47% $0.53 $89.8M
Q3-2024 $815.2M $184.2M $38.2M 4.686% $0.42 $122M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $445.6M $6.056B $3.667B $2.373B
Q2-2025 $474.5M $6.133B $3.759B $2.358B
Q1-2025 $456M $5.811B $3.497B $2.298B
Q4-2024 $544.5M $5.811B $3.482B $2.314B
Q3-2024 $505.7M $6.047B $3.667B $2.363B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $32.8M $72.1M $-24.7M $-75.3M $-28.9M $47.4M
Q2-2025 $53.5M $112.8M $-27M $-78.1M $18.5M $85.8M
Q1-2025 $-19.9M $-51.1M $-12.5M $-28.3M $-88.5M $-63.6M
Q4-2024 $48.5M $122.6M $-41.1M $-27.1M $38.8M $81.5M
Q3-2024 $38.2M $71.1M $-25M $-39M $16.3M $46.1M

Revenue by Products

Product Q3-2024Q1-2025Q2-2025Q3-2025
Color Additives And Inks
Color Additives And Inks
$0 $520.00M $540.00M $510.00M
Specialty Engineered Materials
Specialty Engineered Materials
$0 $310.00M $330.00M $300.00M
Color Additives And Inks Segment
Color Additives And Inks Segment
$520.00M $0 $0 $0
Specialty Engineered Materials Segment
Specialty Engineered Materials Segment
$290.00M $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement Avient’s sales have been fairly steady over the past several years, with only modest ups and downs rather than big swings. Profitability has gradually improved from the early part of the period, with healthier gross and operating margins than before, suggesting better pricing, product mix, or cost control. Net income, however, has been uneven, with one standout year that likely reflects one‑time items and later years settling into a more normal, mid‑range level of earnings. Overall, the income statement points to a business that is stable, slowly improving in quality of profits, but still exposed to cycles and special charges that can make bottom‑line results lumpy from year to year.


Balance Sheet

Balance Sheet The balance sheet shows a company of meaningful scale with a solid base of assets and equity. Cash levels have been consistently healthy for this type of business, providing a reasonable liquidity cushion. Debt is sizeable but has not been growing aggressively, which suggests management is keeping leverage under control rather than continually borrowing more. Equity has trended upward, indicating that the business has been able to build value over time. The picture is of a capital‑intensive industrial company with a manageable, but important, reliance on debt financing that investors should continue to watch, especially in a higher‑rate environment.


Cash Flow

Cash Flow Avient generates positive cash from its operations most years, but the amounts are not large relative to its size, and they move around from year to year. Free cash flow is consistently positive, which is a key strength, yet it is also modest, highlighting that there is not a huge margin for error if conditions weaken. Capital spending is fairly disciplined and predictable, suggesting management is investing enough to maintain and selectively grow the business without overextending. Overall, cash flow supports ongoing operations, debt service, and some reinvestment, but it is not so strong that the company can easily absorb multiple shocks at once without careful capital allocation.


Competitive Edge

Competitive Edge Avient holds a differentiated position in specialty polymers rather than in basic, more commoditized chemicals. Its strengths come from deep technical expertise, a broad portfolio of highly customized materials, and close collaboration with customers who rely on Avient for tailored solutions rather than off‑the‑shelf products. The Dyneema franchise, advanced color and additives capabilities, and strong presence in demanding applications like healthcare and protective gear create meaningful switching costs and brand equity. At the same time, the company still operates in a competitive, cyclical industry where changes in raw‑material costs, customer demand, or new technologies can erode advantages over time, so its edge depends on continuous innovation and service quality.


Innovation and R&D

Innovation and R&D Innovation is a clear centerpiece of Avient’s strategy. The company focuses on high‑value areas such as sustainable materials, lightweighting, and specialized healthcare and high‑performance applications. Its work on bio‑based, recycled, and more easily recyclable plastics lines up well with long‑term regulatory and customer trends toward sustainability. Ownership of unique technologies like Dyneema, plus design and technology centers that co‑develop solutions with customers, give Avient a strong platform to keep launching new products. Future growth will likely depend on how well it can extend these capabilities into fast‑growing niches like electric vehicles, 5G infrastructure, advanced packaging, and composites, as well as on how effectively it uses acquisitions to add new technologies without overpaying or overleveraging the balance sheet.


Summary

Overall, Avient looks like a specialized materials company with stable revenues, gradually improving profit quality, and consistently positive but moderate cash generation. Its balance sheet shows meaningful but controlled leverage and a growing equity base, implying some financial flexibility but also an ongoing need for careful risk management. Competitively, it benefits from technical know‑how, customized solutions, sustainability focus, and distinctive brands like Dyneema that help differentiate it from commodity chemical producers. The main opportunities lie in sustainability, high‑performance applications, and expansion into faster‑growing end markets, while key risks include industry cyclicality, execution on innovation and acquisitions, and the burden of maintaining and servicing its debt in changing economic conditions.